☆ 3.8 Article

Regulation of High-fat Diet-induced Liver Fibrosis by SOCS1 Expression in Hepatic Stellate Cells

JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2024)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Gastroenterology & Hepatology

Healthcare and socioeconomic costs of NAFLD: A global framework to navigate the uncertainties

Alina M. Allen et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) has significant health, economic and social implications, requiring a shift in conceptualization and collaborative action to address the public health threat. The healthcare costs of NAFLD patients are nearly double compared to those without the disease, with the highest costs in advanced fibrosis and end-stage liver disease. NAFLD accounts for the highest increase in disability-adjusted life years (DALYs) among all liver diseases globally. Currently, there are no specific drug therapies for NAFLD and non-alcoholic steatohepatitis (NASH), with uncertainties surrounding cost, treatment duration, and their impact on liver-related outcomes and mortality.

JOURNAL OF HEPATOLOGY (2023)

添加到收藏夹

Article Anatomy & Morphology

An improved method for isolation and flow cytometric characterization of intrahepatic leukocytes from fatty and fibrotic liver tissues

Rajani Kandhi et al.

Summary: This article describes an efficient method for isolating intrahepatic leukocytes from mice fed with high fat diet and proposes a strategy to alleviate autofluorescence during phenotyping by multicolor flow cytometry. The article also introduces a gating strategy for robust identification of different immune cell subsets. These procedures allow simultaneous processing of multiple samples and ensure reliable cell isolation and noise reduction for reliable characterization of intrahepatic leukocytes from fatty liver tissues.

ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2023)

添加到收藏夹

Article Multidisciplinary Sciences

An inducible model for genetic manipulation and fate-tracing of PDGFR & beta;-expressing fibrogenic cells in the liver

Florian Hamberger et al.

Summary: Myofibroblasts are responsible for the production of extracellular matrix protein during liver fibrogenesis. A study was conducted to investigate if the tamoxifen inducible PDGFR-beta-P2A-CreER(T2) mouse can be used to specifically express transgenes in liver mesenchymal cells. The results showed that this mouse model efficiently marked retinoid positive hepatic stellate cells and gave rise to myofibroblasts in different liver fibrosis models.

SCIENTIFIC REPORTS (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver Disease

Leke Wiering et al.

Summary: Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease with a wide range of severity, from simple hepatic steatosis to nonalcoholic steatohepatitis (NASH). NASH can lead to liver fibrosis, cirrhosis, and hepatocellular carcinoma, making hepatic fibrosis an important predictor of outcomes. Recent advancements in understanding the activation and inactivation of hepatic stellate cells, which drive fibrosis development, have shed light on the disease progression in NAFLD/NASH.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

Hepatic fibrosis: 2022 Unmet needs and a blueprint for the future

Scott L. Friedman et al.

Summary: Steady progress has been made in understanding the pathogenesis and clinical consequences of hepatic fibrosis, but effective antifibrotic drugs are yet to be approved. This article highlights the successes and identifies gaps and unmet needs in both experimental and clinical aspects. Clarifying the mechanisms of fibrosis regression and developing better models will expedite drug development, while improving diagnostics and utilizing digital pathology methods can enhance prognostic information and better quantify therapeutic responses.

HEPATOLOGY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis

Aveline Filliol et al.

Summary: The shift in HSC subpopulations during chronic liver disease is associated with a switch from HCC protection to promotion. Quiescent and cytokine-producing HSCs prevent hepatocyte death and HCC development, while activated myofibroblastic HSCs promote proliferation and tumor development through increased stiffness and TAZ and discoidin domain receptor 1 activation.

NATURE (2022)

添加到收藏夹

Review Endocrinology & Metabolism

Hepatic Stellate Cell-Immune Interactions in NASH

James K. Carter et al.

Summary: Nonalcoholic fatty liver disease (NAFLD) is the main cause of liver disease worldwide, and nonalcoholic steatohepatitis (NASH) is a more severe form characterized by significant hepatocellular injury, inflammation, and fibrosis. Recent research has shown that heightened immune cell activity and chronic inflammation play crucial roles in the development of NASH, with hepatic stellate cells (HSCs) being the key drivers of fibrosis.

FRONTIERS IN ENDOCRINOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Heterogeneity of HSCs in a Mouse Model of NASH

Sara Brin Rosenthal et al.

Summary: This study utilized single-cell RNA sequencing to characterize the phenotypic changes of hepatic stellate cells (HSCs) in a NASH model, revealing unexpected heterogeneity of HSC phenotypes under normal and injured states. The NASH livers showed four distinct HSC clusters, including one representing the classic fibrogenic myofibroblast, while livers with NASH regression had one cluster of inactivated HSCs similar to quiescent HSCs.

HEPATOLOGY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Mechanisms and disease consequences of nonalcoholic fatty liver disease

Rohit Loomba et al.

Summary: NAFLD and NASH are leading chronic liver diseases worldwide, causing progressive liver injury that can lead to cirrhosis and hepatocellular carcinoma. These diseases are associated with hepatic glucose and lipid metabolism, and are influenced by genetic, epigenetic, and environmental factors.

CELL (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis-Roles as Putative Treatment Targets?

Alexandra Zisser et al.

Summary: Hepatic fibrosis is a key predictor of mortality in NASH patients, with activated HSCs playing a crucial role in liver scarring. Targeting the fate of HSCs may hold promise for treating NASH-associated hepatic fibrosis.

BIOMEDICINES (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Identification of Lineage-Specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis Resolution

Xiao Liu et al.

GASTROENTEROLOGY (2020)

添加到收藏夹

Article Hematology

Liver fibrosis is driven by protease-activated receptor-1 expressed by hepatic stellate cells in experimental chronic liver injury

Lauren G. Poole et al.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Essential role of suppressor of cytokine signaling 1 (SOCS1) in hepatocytes and macrophages in the regulation of liver fibrosis

Euphrasie Kawila Mafanda et al.

CYTOKINE (2019)

添加到收藏夹

Review Cell Biology

TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019

Bedair Dewidar et al.

CELLS (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis

Byeong-Moo Kim et al.

SCIENTIFIC REPORTS (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Transforming Growth Factor-β (TGF-β) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway

Liu-Ya Tang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2017)

添加到收藏夹

Review Gastroenterology & Hepatology

Targeting hepatic macrophages to treat liver diseases

Frank Tacke

JOURNAL OF HEPATOLOGY (2017)

添加到收藏夹

Review Gastroenterology & Hepatology

Mechanisms of hepatic stellate cell activation

Takuma Tsuchida et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Both MAPK and STAT3 signal transduction pathways are necessary for IL-6-dependent hepatic stellate cells activation

Polina Kagan et al.

PLOS ONE (2017)

添加到收藏夹

Review Pharmacology & Pharmacy

Hepatic stellate cells as key target in liver fibrosis

Takaaki Higashi et al.

ADVANCED DRUG DELIVERY REVIEWS (2017)

添加到收藏夹

Review Immunology

Liver macrophages in tissue homeostasis and disease

Oliver Krenkel et al.

NATURE REVIEWS IMMUNOLOGY (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Negative regulation of the hepatic fibrogenic response by suppressor of cytokine signaling 1

Rajani Kandhi et al.

CYTOKINE (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Pathogenesis of Nonalcoholic Steatohepatitis

Mariana Verdelho Machado et al.

GASTROENTEROLOGY (2016)

添加到收藏夹

Editorial Material Gastroenterology & Hepatology

Nonalcoholic Fatty Liver Disease: Fibrosis Portends a Worse Prognosis

Dawn M. Torres et al.

HEPATOLOGY (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up

Mattias Ekstedt et al.

HEPATOLOGY (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

β-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis

Peri Kocabayoglu et al.

JOURNAL OF HEPATOLOGY (2015)

添加到收藏夹

Review Gastroenterology & Hepatology

NAFLD: A multisystem disease

Christopher D. Byrne et al.

JOURNAL OF HEPATOLOGY (2015)

添加到收藏夹

Review Gastroenterology & Hepatology

Hepatic fibrosis: Concept to treatment

Christian Trautwein et al.

JOURNAL OF HEPATOLOGY (2015)

添加到收藏夹

Article Biochemistry & Molecular Biology

Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma

Y. Gui et al.

ONCOGENE (2015)

添加到收藏夹

Review Biochemistry & Molecular Biology

SOCS proteins in regulation of receptor tyrosine kinase signaling

Julhash U. Kazi et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2014)

添加到收藏夹

Article Gastroenterology & Hepatology

O147 HEPATIC STELLATE CELLS ARE THE MAJOR SOURCE OF COLLAGEN IN MURINE MODELS OF LIVER FIBROSIS

C.H. Österreicher et al.

JOURNAL OF HEPATOLOGY (2014)

添加到收藏夹

Article Gastroenterology & Hepatology

Hepatic Macrophages But Not Dendritic Cells Contribute to Liver Fibrosis by Promoting the Survival of Activated Hepatic Stellate Cells in Mice

Jean-Philippe Pradere et al.

HEPATOLOGY (2013)

添加到收藏夹

Article Pathology

An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis

Masahiko Matsumoto et al.

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2013)

添加到收藏夹

Review Gastroenterology & Hepatology

NAFLD, NASH and liver cancer

Gregory A. Michelotti et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology

Ingmar Mederacke et al.

NATURE COMMUNICATIONS (2013)

添加到收藏夹

Review Gastroenterology & Hepatology

Fibrosis-dependent mechanisms of hepatocarcinogenesis

David Y. Zhang et al.

HEPATOLOGY (2012)

添加到收藏夹

Article Endocrinology & Metabolism

Macrophage Deletion of SOCS1 Increases Sensitivity to LPS and Palmitic Acid and Results in Systemic Inflammation and Hepatic Insulin Resistance

Nirupa Sachithanandan et al.

DIABETES (2011)

添加到收藏夹

Article Biochemistry & Molecular Biology

Suppressor of cytokine signaling 1 (SOCS1) limits NFκB signaling by decreasing p65 stability within the cell nucleus

Julia Strebovsky et al.

FASEB JOURNAL (2011)

添加到收藏夹

Article Biochemistry & Molecular Biology

TLR4 enhances TGF-β signaling and hepatic fibrosis

Ekihiro Seki et al.

NATURE MEDICINE (2007)

添加到收藏夹

Article Gastroenterology & Hepatology

Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice

Piotr Czochra et al.

JOURNAL OF HEPATOLOGY (2006)

添加到收藏夹

Article Immunology

Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation

A Mansell et al.

NATURE IMMUNOLOGY (2006)

添加到收藏夹

Article Cell Biology

Smad2 and smad3 play different roles in rat hepatic stellate cell function and α-smooth muscle actin organization

M Uemura et al.

MOLECULAR BIOLOGY OF THE CELL (2005)

添加到收藏夹

Article Gastroenterology & Hepatology

Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression

MB Bansal et al.

JOURNAL OF HEPATOLOGY (2005)

添加到收藏夹

Review Biochemistry & Molecular Biology

Regulation of PDGF and its receptors in fibrotic diseases

JC Bonner

CYTOKINE & GROWTH FACTOR REVIEWS (2004)

添加到收藏夹

Article Immunology

SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis

T Yoshida et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2004)

添加到收藏夹

Article Immunology

SOCS3 negatively regulates IL-6 signaling in vivo

BA Croker et al.

NATURE IMMUNOLOGY (2003)

添加到收藏夹

Article Immunology

SOCS1/JAB is a negative regulator of LPS-induced macrophage activation

I Kinjyo et al.

IMMUNITY (2002)

添加到收藏夹

Review Immunology

Suppressors of cytokine signalling (SOCS) in the immune system

WS Alexander

NATURE REVIEWS IMMUNOLOGY (2002)

添加到收藏夹

Article Gastroenterology & Hepatology

Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice

K Kovalovich et al.

HEPATOLOGY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.